Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticancer therapy using glucuronate modified long-circulating liposomes.

Oku1

  • 1Department of Radiobiochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Yada, Shizouka, Japan

Advanced Drug Delivery Reviews
|June 6, 2000
PubMed
Summary

Researchers developed PGlcUA-modified liposomes that avoid RES trapping, enabling effective tumor targeting and enhanced drug delivery for cancer treatment and imaging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tandem Cyclization of Alkynylmetals Bearing a Remote Leaving Group via Cycloalkylidene Carbenes.

Organic letters·2000
Same author

Modulated structure of Ag2SnO3 studied by high-resolution electron microscopy

Acta crystallographica. Section B, Structural science·2000
Same author

Ring-expansion of thioacetal ring via bicyclosulfonium ylide. Effect Of protic nucleophile on ylide intermediate

The Journal of organic chemistry·2000
Same author

Delivery of contrast agents for positron emission tomography imaging by liposomes.

Advanced drug delivery reviews·2000
Same author

Asymmetric synthesis of axially chiral biaryls via desymmetrization of 2,2',6,6'-tetrahydroxybiphenyl using 1,4-Di-O-benzyl-L-threitol as a chiral template

The Journal of organic chemistry·2000
Same author

Asymmetric desymmetrization of 2,2',6,6'-tetrahydroxybiphenyl through annulation with enantiomerically pure bis(mesylate)

Organic letters·2000

Area of Science:

  • Nanomedicine
  • Drug Delivery Systems
  • Oncology

Background:

  • Conventional liposomes are rapidly cleared by the reticuloendothelial system (RES), limiting their therapeutic applications.
  • Targeting non-RES cells with traditional liposomes is challenging due to premature systemic clearance.

Purpose of the Study:

  • To develop long-circulating liposomes that evade RES sequestration.
  • To enhance passive tumor targeting and improve the efficacy of encapsulated anticancer agents.

Main Methods:

  • Modification of liposomes with a glucuronic acid derivative (PGlcUA) and polyethylene glycol (PEG).
  • Evaluation of liposome circulation time and RES-trapping avoidance.
  • Assessment of passive targeting to tumor tissues via enhanced permeability and retention (EPR) effect.

Related Experiment Videos

  • Testing the efficacy of PGlcUA-liposome encapsulated drugs (adriamycin, vincristine) in preclinical models.

    • Main Results:

    • PGlcUA-modified liposomes exhibited prolonged circulation times, effectively evading RES uptake.
    • These liposomes demonstrated significant accumulation in tumor tissues due to leaky vasculature.
    • Encapsulation of adriamycin and vincristine within PGlcUA liposomes resulted in enhanced antitumor efficacy.
    • PGlcUA liposomes showed promise in photodynamic therapy and with novel anticancer agents.

    Conclusions:

    • PGlcUA-modified liposomes represent a promising drug delivery platform for improved cancer therapy.
    • Their long-circulating nature and passive tumor targeting capabilities overcome limitations of conventional liposomes.
    • These liposomes enhance the efficacy of various anticancer agents and are suitable for tumor imaging and treatment.